%PDF-1.4
%
23 0 obj
<>
endobj
21 0 obj
<>
endobj
141 0 obj
<>stream
Acrobat Distiller 5.00 for Macintosh
2005-02-15T20:54:00Z
2024-03-29T05:08:34-07:00
2024-03-29T05:08:34-07:00
QuarkXPress(tm) 5.01
application/pdf
Heather
2004-815-S74
uuid:06ae2ccc-1dd2-11b2-0a00-8d0827fd5800
uuid:06ae2cd0-1dd2-11b2-0a00-6a0000000000
endstream
endobj
8 0 obj
<>
endobj
11 0 obj
<>
endobj
24 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
146 0 obj
[149 0 R]
endobj
147 0 obj
<>stream
q
0 783 585 -783 re
W n
q
0.06 783 585 -783 re
W n
/CS0 CS 0 0 0 1 SCN
/GS0 gs
40.464 67.5 m
544.536 67.5 l
S
/CS0 cs 0 0 0 0 scn
/GS1 gs
89.909 72.25 407.5 -10.833 re
f
0.5 w
/GS0 gs
89.909 72.25 407.5 -10.833 re
S
301.5 738 243.036 -660.727 re
f
BT
0 0 0 1 scn
/T1_0 1 Tf
0.02 Tc 0.4465 Tw 10 0 0 10 302.5 729.8297 Tm
[(Associa)29 (te Pr)34 (ofessor)94 (,)-716 (Departments of)-809 (Imm)21 (unolo)21 (gy)87 (,)]TJ
0.5773 Tw 0 -1.2 TD
[(Medical Bioph)56 (ysics and Medicine)50 (,)-847 (Uni)14 (v)14 (ersity of)]TJ
-0.0811 Tc 0 Tw T*
[(To)-101.1 (r)]TJ
0.02 Tc 0.5038 Tw 1.5289 0 Td
[(onto)36 (,)-774 (T)101 (or)34 (onto;)-774 (J)52 (ohn T)111 (.)-774 (Sib)14 (ley)87 (,)-774 (MD)50 (,)-774 (FR)80 (CPC)29 (,)]TJ
0.0047 Tc 0.3703 Tw -1.529 -1.2 Td
[(Pr)34 (ofessor of)-718 (Medicine)50 (,)-625 (Uni)14 (v)14 (ersity of)-718 (Saska)29 (tche)14 (w)19 (an,)]TJ
0 Tc 0.31059 Tw T*
[(Saska)29 (toon;)-561 (Brian J)109 (.)-561 (Under)14 (do)27 (wn,)-561 (PhD)50 (,)-561 (MDS Ca)21 (pital)]TJ
0.0041 Tw T*
[(Corp)64 (.)-254 (and Uni)14 (v)14 (ersity Medical Disco)33 (v)14 (eries)50 (,)-254 (Inc.,)-254 (T)101 (or)34 (onto)36 (,)]TJ
0 Tw T*
(Canada.)Tj
/T1_1 1 Tf
0 -2.4 TD
(REFERENCES)Tj
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 302.8425 625.9767 Tm
[(1.)-1013 (Scallon B)29 (,)-275 (Cai A,)-275 (Solo)27 (wski N)57 (,)-275 (et al.)-275 (Binding and functional)]TJ
1.7981 -1.2 Td
[(comparisons of)-368 (tw)33 (o types of)-368 (tumor necr)34 (osis factor anta)22 (gonists)64 (.)]TJ
-0.0139 -1.2 Td
[(J Phar)-21 (macol Exp Ther 2002;301:418-26.)]TJ
-1.7842 -1.2 Td
[(2.)-1013 (Scallon BJ)87 (,)-275 (Moor)13 (e MA,)-275 (T)87 (rinh H,)-275 (Knight DM,)-275 (Ghr)7 (a)40 (y)7 (e)15 (b Chimeric)]TJ
1.7981 -1.2 Td
[(anti-TNF-alpha monoclonal antibod)29 (y cA2 binds r)13 (ecombinant)]TJ
0 -1.2 TD
[(tr)7 (ansmembr)7 (ane TNF-alpha and acti)14 (v)20 (a)29 (tes imm)21 (une ef)29 (fector)]TJ
T*
[(functions)64 (.)-275 (Cytokine 1995;7:251-9.)]TJ
-1.7981 -1.2 Td
[(3.)-1013 (W)82 (a)22 (gner U)72 (,)-275 (Pier)13 (er M,)-275 (W)82 (ahle M,)-275 (Moritz F)120 (,)-275 (K)14 (altenhauser S)43 (,)]TJ
1.7981 -1.2 Td
[(Hantzschel H.)-275 (Ex vi)14 (v)27 (o homeosta)29 (tic pr)34 (olifer)7 (a)29 (tion of)-368 (CD4+ T cells)]TJ
T*
[(in rheuma)29 (toid arthritis is d)29 (ysr)13 (egula)29 (ted and dri)14 (v)14 (en b)20 (y)]TJ
T*
[(membr)7 (ane-anchor)13 (ed TNF alpha.)-275 (J Imm)21 (unol 2004;173:2825-33.)]TJ
-1.7981 -1.2 Td
[(4.)-1013 (Di Sa)43 (ba)29 (tino A,)-275 (Ciccocioppo R,)-275 (Cinque B)29 (,)-275 (et al.)-275 (Defecti)14 (v)14 (e m)21 (ucosal)]TJ
1.7981 -1.2 Td
[(T cell dea)29 (th is sustaina)43 (b)14 (l)21 (y r)13 (e)14 (v)14 (erted b)20 (y inf)-7 (lixima)43 (b in a caspase)]TJ
T*
[(dependent pa)29 (thw)19 (a)40 (y in Cr)34 (ohn)36 (\325)81 (s disease)57 (.)-275 (Gut 2004;53:70-7.)]TJ
-0.00481 Tc 0.0248 Tw -1.7981 -1.2 Td
[(5.)-1018 (V)74 (an den Br)7 (ande JM,)-270 (Br)7 (aa)29 (t H,)-270 (v)20 (an den Brink GR,)-270 (et al.)-270 (Inf)-7 (lixima)43 (b)]TJ
0 Tc 0 Tw 1.7981 -1.2 Td
(b)Tj
0.02499 Tw 0.53 0 Td
[(ut not etaner)13 (cept induces a)21 (poptosis in lamina pr)34 (opria)]TJ
-0.03909 Tc 0 Tw -0.53 -1.2 Td
[(T-)-39.1 (l)]TJ
0 Tc 0.02499 Tw 1.2109 0 Td
[(ymphocytes fr)34 (om pa)29 (tients with Cr)34 (ohn)36 (\325)81 (s disease)57 (.)]TJ
-1.2109 -1.2 Td
[(Gastr)34 (oenter)34 (olo)21 (gy 2003;124:1774-85.)]TJ
-1.7981 -1.2 Td
[(6.)-1013 (W)82 (allis RS)43 (,)-275 (Br)34 (oder MS)43 (,)-275 (W)109 (ong JY)163 (,)-275 (Hanson ME,)-275 (Beenhouw)15 (er DO)57 (.)]TJ
1.7981 -1.2 Td
[(Gr)7 (an)36 (uloma)29 (tous infectious diseases associa)29 (ted with tumor necr)34 (osis)]TJ
T*
[(factor anta)22 (gonists)64 (.)-275 (Clin Infect Dis 2004;38:1261-5.)]TJ
ET
0 0 0 0 scn
40.464 738.001 243.036 -415.139 re
f
BT
0 0 0 1 scn
/T1_1 1 Tf
0 Tw 10 0 0 10 41.464 729.8307 Tm
(R)Tj
0.02499 Tw 0.676 0 Td
[(OUNDT)50 (ABLE P)114 (AR)43 (TICIP)114 (ANTS:)]TJ
/T1_0 1 Tf
0.0045 Tc 0.3705 Tw -0.676 -1.2 Td
[(Clinical Pr)34 (o)21 (gr)7 (am Chair)7 (:)-625 (Ed)43 (w)19 (ar)14 (d C)29 (.)-625 (K)34 (eystone)50 (,)-625 (MD)50 (,)]TJ
0 Tc 0.1212 Tw T*
[(FR)80 (CPC)29 (,)-371 (Pr)34 (ofessor of)-464 (Medicine)50 (,)-371 (Uni)14 (v)14 (ersity of)-464 (T)101 (or)34 (onto)36 (,)]TJ
-0.1011 Tc 0 Tw T*
[(To)-101.2 (r)]TJ
0 Tc 0.1261 Tw 1.469 0 Td
[(onto)36 (,)-376 (Canada;)-376 (Scientific Pr)34 (o)21 (gr)7 (am Chair)7 (:)-376 (Char)7 (les A.)]TJ
0.30589 Tw -1.469 -1.2 Td
[(Dinar)13 (ello)36 (,)-556 (MD)50 (,)-556 (Pr)34 (ofessor of)-649 (Medicine)50 (,)-556 (Uni)14 (v)14 (ersity of)]TJ
0.2988 Tw T*
[(Color)7 (ado)36 (,)-549 (Den)40 (v)14 (er)94 (,)-549 (CO)36 (,)-549 (USA.)-549 (F)60 (aculty:)-549 (Stefan Ehlers)50 (,)]TJ
0.2628 Tw T*
[(MD)50 (,)-513 (R)54 (esear)13 (ch Center Borstel,)-513 (Di)14 (vision of)-605 (Molecular)]TJ
0.03 Tw T*
[(Infection Biolo)21 (gy)87 (,)-280 (Borstel,)-280 (Ger)-21 (man)40 (y;)-280 (Douglas R.)-280 (Gr)13 (een,)]TJ
0.00459 Tw T*
[(PhD)50 (,)-255 (Adjunct Pr)34 (ofessor of)-347 (Biolo)21 (gy)87 (,)-255 (La J)52 (olla Institute f)40 (or)]TJ
0.2402 Tw T*
[(Aller)27 (gy and I)20 (m)20 (m)]TJ
-0.02 Tc 0.2403 Tw 7.6434 0 Td
[(unolo)21 (gy)87 (,)-470 (Uni)14 (v)14 (ersity of)-563 (Calif)40 (ornia,)-470 (San)]TJ
0.08031 Tw -7.6434 -1.2 Td
[(Diego)36 (,)-310 (CA,)-310 (USA;)-310 (Boulos Har)7 (aoui,)-310 (MD)50 (,)-310 (FR)80 (CPC)29 (,)-310 (Clinical)]TJ
0.1459 Tw T*
[(Associa)29 (te Pr)34 (ofessor of)-469 (Medicine)50 (,)-376 (Uni)14 (v)14 (ersit\216 de Montr\216al,)]TJ
-0.02499 Tc 0.2352 Tw T*
[(Montr)13 (eal,)-460 (Canada;)-460 (Iv)20 (an Nestor)34 (o)33 (v)86 (,)-460 (PhD)50 (,)-460 (F)39 (ello)27 (w)87 (,)-460 (Amgen,)]TJ
0.1642 Tw T*
[(Inc.,)-389 (Thousand Oaks)50 (,)-389 (CA,)-389 (USA;)-389 (P)13 (aul P)149 (.)-389 (T)74 (ak,)-389 (PhD)50 (,)-389 (MD)50 (,)]TJ
-0.0065 Tc 0.35651 Tw T*
[(Pr)34 (ofessor of)-693 (Medicine)50 (,)-600 (Dir)13 (ector)94 (,)-600 (Di)14 (vision of)-693 (Clinical)]TJ
-0.02499 Tc -0.02589 Tw T*
[(Imm)21 (unolo)21 (gy and Rheuma)29 (tolo)21 (gy)87 (,)-199 (Academic Medical Center)94 (,)]TJ
-0.0157 Tc 0.36571 Tw T*
[(Amster)14 (dam;)-600 (J)47 (an M.H.)-600 (v)20 (an den Br)7 (ande)50 (,)-600 (MD)50 (,)-600 (F)39 (ello)27 (w)87 (,)]TJ
-0.02271 Tc 0.3727 Tw T*
[(Gastr)34 (oenter)34 (olo)21 (gy)87 (,)-600 (La)43 (bor)7 (a)29 (tory f)40 (or Experimental Internal)]TJ
-0.0168 Tc 0.36681 Tw T*
[(Medicine)50 (,)-600 (Academic Medical Center)94 (,)-600 (Amster)14 (dam,)-600 (The)]TJ
-0.02499 Tc 0.35699 Tw T*
[(Nether)7 (lands)64 (.)-582 (Canadian Ad)21 (visors:)-582 (Andr\216 Beaulieu,)-582 (MD)50 (,)]TJ
0.0994 Tw T*
[(FR)80 (CPC)29 (,)-324 (Di)14 (vision of)-417 (Rheuma)29 (tolo)21 (gy)87 (,)-324 (Centr)13 (e Hospitalier de)]TJ
-0.02271 Tc 0.3727 Tw T*
[(l\325Uni)14 (v)14 (ersit\216 La)75 (v)20 (al,)-600 (St-F)79 (o)36 (y;)-600 (J)47 (an P)149 (.)-600 (Dutz,)-600 (MD)50 (,)-600 (FR)80 (CPC)29 (,)]TJ
-0.02499 Tc 0.0401 Tw T*
[(Assistant Pr)34 (ofessor)94 (,)-265 (Di)14 (vision of)-358 (Der)-21 (ma)29 (tolo)21 (gy)87 (,)-265 (Uni)14 (v)14 (ersity of)]TJ
-0.0219 Tc 0.3719 Tw T*
[(British Columbia,)-600 (V)74 (ancouv)14 (er)21 (;)-600 (Hani El-Ga)43 (bala)62 (wy)87 (,)-600 (MD)50 (,)]TJ
-0.02229 Tc 0.3723 Tw T*
[(FR)80 (CPC)29 (,)-600 (Pr)34 (ofessor)94 (,)-600 (Uni)14 (v)14 (ersity of)-693 (Manitoba,)-600 (W)23 (innipeg;)]TJ
-0.0609 Tc 0 Tw T*
(Fr)Tj
-0.02499 Tc 0.26579 Tw 0.9591 0 Td
[(ank R.)-491 (Jirik,)-491 (MD)50 (,)-491 (FR)80 (CPC)29 (,)-491 (Pr)34 (ofessor)94 (,)-491 (Department of)]TJ
-0.0051 Tw -0.9591 -1.2 Td
[(Biochemistry and Molecular Biolo)21 (gy)87 (,)-220 (Uni)14 (v)14 (ersity of)-313 (Calgary)87 (,)]TJ
0.02 Tw T*
[(Calgary;)-245 (W)82 (alter Maksymo)27 (wy)14 (ch,)-245 (MB)29 (,)-245 (ChB)29 (,)-245 (F)107 (A)43 (CP)116 (,)-245 (FR)80 (CPC)29 (,)]TJ
0.0574 Tw T*
[(FR)80 (CP \(UK\),)-282 (Pr)34 (ofessor of)-375 (Medicine)50 (,)-282 (Uni)14 (v)14 (ersity of)-375 (Alberta,)]TJ
-0.005 Tc 0.463 Tw T*
[(Edmonton;)-708 (J)47 (anet E.)-708 (P)47 (ope)50 (,)-708 (MD)50 (,)-708 (FR)80 (CPC)29 (,)-708 (Associa)29 (te)]TJ
-0.0183 Tc 0.3683 Tw T*
[(Pr)34 (ofessor of)-693 (Medicine)50 (,)-600 (Epidemiolo)21 (gy and Biosta)29 (tistics)50 (,)]TJ
-0.02499 Tc 0.15041 Tw T*
[(Uni)14 (v)14 (ersity of)-468 (W)96 (estern Ontario)36 (,)-375 (London;)-375 (Pr)34 (oton R)42 (ahman,)]TJ
-0.02071 Tc 0.0939 Tw T*
[(MD)54 (,)-314 (F)4 (R)84 (CPC)33 (,)-319 (Assistant Pr)33 (ofessor of)-417 (Medicine)49 (,)]TJ
0 Tc 0 Tw 19.8736 0 Td
(Memorial)Tj
0.0152 Tw -19.8736 -1.2 Td
[(Uni)14 (v)14 (ersity)87 (,)-265 (St.)-265 (J)52 (ohn)36 (\325)81 (s;)-265 (R)88 (obert K.)-265 (R)88 (otta)21 (pel,)-265 (MD)50 (,)-265 (FR)80 (CPC)29 (,)]TJ
ET
0 0 0 0 scn
40.464 60.336 513.774 -14.987 re
f
BT
0 0 0 1 scn
/T1_2 1 Tf
0 Tw 8 0 0 8 41.464 53.5996 Tm
(2)Tj
0.02499 Tw 36.8512 0 Td
[(The J)50 (ournal of)-346 (Rheumatolog)14 (y 2005,)-275 (V)72 (olume 32 Supplement 74)]TJ
ET
Q
Q
q
1 0 0 1 1 -5 cm
0 0 585 783 re
W n
1 0 0 1 -1 5 cm
BT
/T1_3 8 Tf
93.828 64 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
/T1_4 1 Tf
10 0 0 10 513 8 Tm
( )Tj
0 0.48627 0.77255 rg
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
27 0 obj
<>
endobj
4 0 obj
<>
endobj
45 0 obj
<>
endobj
66 0 obj
<>
endobj
145 0 obj
<>
endobj
46 0 obj
<>
endobj
58 0 obj
<>stream
HdTkTSWp/1uroERDmeS|<Q@B &&$!(ࠠPfFECEZqY,vL(3snzX3sc߬||;{hG#EI+EƼW$IKvc+e<|<>4<
/+|o!(jl3JjMZjm)SbZg(RL*ORS6P;%Mby8Mv*JI324Ăgrq
'3g)i*&ULEJ3JLLE8MI$WY !:$ Epم#aO$AV-A8B&ͨ}#9_yjU| ?zk;E[__;҄kb~+R4=4 =.O]7*t^d)RMuq]\V$צJq5-uQ3p)1|w>
Ap x^_BR"
: fll}B>vi
$BT50\squ:36⼣H*H.b uaRcncYG~[u²3}91`pkCeeԂ'[ط@-[1:|,lՆuЛ"2ip[~%o˃۔3Rg(&5
B%HH7|p"uhU7;47'cͩ0IV5u7ӣO=YArA#
2&?//ك
Ʀ!}7?a?dͬ9L+U|ӓ7+uŢ+fSRiA
ly(L8^0wO4[0_2;8M.c]Ϊ 3=ٌ=(7y{>H9TTʤpx pXĩdsJE6y;^ms O^\?p3$X?7 ˑX0[Y !@*(<L0.om46
'yq0(M;.,"<;$r@7X+k;ITmLUa͚.|;y5~q/2k)C+\(>A|t~M/2@+>dB^ahBYXSi!kkkB[3-EytHݾahp:<
x$ە&= ߿TjSkFې!@( ҅mt(#Qo4U&Qg s%rtT4%H@WY*W=nI>g EjqH[`4"#־V
X7*y5 LOg6QtZB|7w|JKJ2H}AB|
$`X:p+v+҃NK3)7+>@0^ecʾz73&kp*YJ]Y!f;?wcǸv;E^WEsGlѶɾ{mO]o9LM
<1;f/CY1~t &gxdP0Sr`@_HY?v?O.~vu1D+Co1n(=h374 baRZQʮ+|D]dB(5~$K*H8Mor2q[S/NSR^pfsʵщ??2+.MY&IXw eg[Qq`OO
t&茾TP&3s=]="MvLڲzSuLk`赋P%~p5][#tYRюzt|e1)̀x[evkI`.//+,l{kk[p5|FwY;w%M9
ܛku4
th4Q1FcѪET^,`Yv}_w4z+O6S&m
YiZ|\N*Zi110ᯉ܁>%NgT(6Gh5xy :ыVzTDKZ^;I+|D,!Fs>gŀgzxDDQ]po^v>
0?y/#8\3s3%wk2P"يkV@0Q3{@uVI2ׯc2,cڡocognU3FD5]%YS5ׇ"jhc>0vx#PHy :lVX̜bN+UՈbqAwldp>.85\qe4Gup9[(rmjqt]P+(D=T$*y^$,Qs:ZY%_F?xw2.|Ui:9M~e~>`}w3t|~Uۯ!K%/ݾnm/:i
W(kst0;ḯ`I
n;o$B5)!du3=UFue>~Wb4m߃=O|Rkd#:^*&%^Q鱯Ob'-e}eNf`<.lſ)B6 |isOA:l5sT[P42f
WW 3VJIC7zj?
r7-'Gpfy&9C_
Zi\{[[+˸%c4_DHgZ
9$hT8F=Q =NCS;ʳ;|::̟Ĥ6HXp3-.jU؉1F݃>XkA"#j{l59py*ezVĀT9!bCmǩ]4Vx qRJ5s53 z[ @f8gklBEk*zPȔCӐ_E,Bc<jv(TAŰ*.Bc&y
f} !i
l]:ۤPuvp^BMFivv42 "&Ws+S\_l?Gcw`8"ۺd45ӊ"pX^!H/?**= Xg^cl?>`fPL^J94TLJI@ω<%lpVr@<zMN9CrOٺ$ly?r#oU B`F0הAU&4]ŀz?P$}b)+ڹCݏ'4H AHT(YeJ+=#Ln_q1%zތ3N*%ʾ0h61/IJFKK]T--E_:LBfN5YL+涸-#xsVIڱL:< 6 W8 4?ssVX+I$@
z/ED*?&:
נp@=$7mNΖ ZMt54Rv Wi~lB9:KW,!vܜ G[LBؖC*ycոspi?S
*'l E2Q9WMzS=PĒ94*!-H0}/-M5Pd
F(>p2\ikT?G"NPVq4 oyƎQAbY|}_b}\proswy!%nsvwzpw{A?e~{r7|ד̤
-6
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>stream
HlmTg^5eX%dfK%j4@C +%0BB]ta]`#&XEQ(MlQXrĖ6&61&``MCģ3;M{_zzf>3eaYvkEyHDTmgRbfB}
ӡ;G)1lˁlWU꤇ϓ>"e9<:B_K=>WQt,niwscHZ/UРWpT6JJ)zdSpVccYff>,`EQ#Ke3&3+!!dž
wiƗrM'+z%jdH3T5)t*P8*r[~G!xٹIu